Skip to main navigation
COMPANY
PRODUCTS AND PIPELINE
INVESTORS
CAREERS
IN THE NEWS
CONTACT US
User Menu
LOGIN
ABOUT
LEADERSHIP
BOARD
PARTNERSHIPS
SUSTAINABILITY
MEDICAL EDUCATIONAL GRANTS
INVESTIGATOR SPONSORED TRIALS
INVESTOR RELATIONS
PRESS RELEASES
EVENTS + PRESENTATIONS
FINANCIALS & FILINGS
CORPORATE GOVERNANCE
STOCK INFORMATION
ANALYST COVERAGE
INVESTOR FAQS
CONTACT US
OPPORTUNITIES
CULTURE
BENEFITS
COMPANY
PRODUCTS AND PIPELINE
INVESTORS
CAREERS
IN THE NEWS
CONTACT US
Back
INVESTORS
Event Details
IR Menu
☰
Revance Nav Menu
Investor Relations
Press Releases
Events + Presentations
Events
Presentations and Corporate Materials
Financials & Filings
SEC Filings
Annual Reports and Proxies
Quarterly Results
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Investor FAQs
Contact Us
Revance Therapeutics 2022 Third Quarter Financial Results
November 08, 2022 at 4:30 PM EST
Listen to Webcast
Toolkit
Print Page
Print Materials
Email Alerts
Download Library
RSS Newsfeed
Share
Facebook
LinkedIn
